Clinical Trial Update: Fluzoparib and Abiraterone in the preSurgery Treatment of Prostate Cancer: FAST Trial [Phase 2]

View source ↗

Summary

Phase 2 FAST trial evaluating fluzoparib and abiraterone as pre-surgery treatment for high-risk prostate cancer in a neoadjuvant setting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abiraterone (abiraterone)
• Fluzoparib (fluzoparib)

Snippet

Sponsor: Fudan University | Conditions: High-risk Prostate Cancer, Neoadjuvant Therapy | Phase 2 | Status: UNKNOWN